Chromocenter
About:
Chromocenter is a biopharmaceuticals manufacturing company that develops protein production courses and chromosome analysis services.
Website: http://chromocenter.com
Twitter/X: chromocenter_jp
Top Investors: SMBC Venture Capital, Mitsubishi UFJ Capital, Osaka University Venture Capital, QB Capital, Shinkin Capital
Description:
Chromocenter is a next generation biopharmaceuticals Manufacturing company. It uses technologies such as artificial chromosome vectors, mainly for drug discovery such as medical pharmaceuticals
Total Funding Amount:
558M JPY
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Tokyo, Tokyo, Japan
Founded Date:
2005-01-01
Contact Email:
chromo(AT)chromocenter.com
Founders:
Takayuki Matsuoka
Number of Employees:
1-10
Last Funding Date:
2021-03-24
IPO Status:
Private
Industries:
© 2025 bioDAO.ai